Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1678670
PUBLISHER: Grand View Research | PRODUCT CODE: 1678670
Europe Hospital Acquired Infections Diagnostics Market Size, Share & Trends Analysis Report By Test Type, By Infection Type, By Product, By Type, By Country, And Segment Forecasts, 2025 - 2030
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Europe Hospital Acquired Infections Diagnostics Market Growth & Trends:
The Europe hospital acquired infections diagnostics market size is anticipated to reach USD 1.61 billion by 2030, growing at a CAGR of 1.2% during the forecast period, according to a new report by Grand View Research, Inc. In recent years, the prevalence of infections, particularly sepsis and surgical site infections, has driven a surge in demand for effective diagnostic solutions. In Europe, approximately 3.4 million sepsis cases occurred annually, leading to nearly 700,000 deaths each year, highlighting the urgent need for advanced diagnostic tools. The rising incidence of bloodstream infections (BSIs) compelled healthcare providers to implement robust diagnostic measures, presenting substantial market opportunities for companies specializing in hospital-acquired infection (HAI) diagnostics.
Technological advancements significantly contributed to market growth, with innovations in molecular diagnostics and rapid testing methods enhancing the accuracy and speed of HAI detection. These developments allowed for more timely identification, ultimately improving patient outcomes.
In addition, increasing healthcare expenditure across European countries facilitated the adoption of HAI diagnostics. Investments in healthcare infrastructure and proactive government initiatives aimed at infection control fostered a supportive environment for market expansion. Heightened patient awareness regarding HAIs further amplified the demand for effective diagnostic solutions, as informed patients and healthcare providers alike sought timely diagnostics, propelling market growth for innovative diagnostic products.
Europe Hospital Acquired Infections Diagnostics Market Report Highlights:
- Based on test type, the conventional tests dominated the market in 2024. Molecular tests, especially PCR-based methods, are projected to achieve the fastest CAGR of 1.5% during the forecast period, becoming essential for diagnosing hospital-acquired infections in Europe.
- Based on infection type, the UTI segment led the Europe hospital acquired infections diagnostics industry in 2024, accounting for a revenue share of 21.6% in 2024.
- In 2024, the consumables product segment captured the highest market share, driven by the need for accurate diagnosis, regulatory compliance, and high testing volumes in European hospitals.
- Based on type, the urinalysis segment is expected to grow lucratively due to rising UTI rates in hospitals, particularly in urology units, driven by high catheterization and demand for effective diagnostics.
- Key players operating in the market include BIOMERIEUX; Abbott; F. Hoffmann-La Roche Ltd; Siemens Healthineers AG; BD; HC Bioscience; QIAGEN; Thermo Fisher Scientific Inc.; Meridian Bioscience, Inc.; Hologic, Inc.
- In January 2025, BioMerieux announced its intent to pursue acquisitions with EUR 3bn- EUR 4bn available, enhancing its core segments within the diagnostics market.
Product Code: GVR-4-68040-513-7
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Test Type
- 1.2.2. Infection Type
- 1.2.3. Product
- 1.2.4. Type
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Europe Hospital Acquired Infections Diagnostics Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
Chapter 4. Europe Hospital Acquired Infections Diagnostics Market: Test Type Business Analysis
- 4.1. Test Type Market Share, 2024 & 2030
- 4.2. Test Type Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Test Type, 2018 to 2030 (USD Million)
- 4.4. Molecular
- 4.4.1. Molecular Market, 2018 - 2030 (USD Million)
- 4.5. Conventional
- 4.5.1. Conventional Market, 2018 - 2030 (USD Million)
Chapter 5. Europe Hospital Acquired Infections Diagnostics Market: Infection Type Business Analysis
- 5.1. Infection Type Market Share, 2024 & 2030
- 5.2. Infection Type Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Infection Type, 2018 to 2030 (USD Million)
- 5.4. UTI
- 5.4.1. UTI Market, 2018 - 2030 (USD Million)
- 5.5. Pneumonia
- 5.5.1. Pneumonia Market, 2018 - 2030 (USD Million)
- 5.6. Surgical Site Infection
- 5.6.1. Surgical Site Infection Market, 2018 - 2030 (USD Million)
- 5.7. Blood Stream Infections
- 5.7.1. Blood Stream Infections Market, 2018 - 2030 (USD Million)
- 5.8. Others
- 5.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Europe Hospital Acquired Infections Diagnostics Market: Product Business Analysis
- 6.1. Product Market Share, 2024 & 2030
- 6.2. Product Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 6.4. Consumables
- 6.4.1. Consumables Market, 2018 - 2030 (USD Million)
- 6.5. Instruments
- 6.5.1. Instruments Market, 2018 - 2030 (USD Million)
Chapter 7. Europe Hospital Acquired Infections Diagnostics Market: Type Business Analysis
- 7.1. Type Market Share, 2024 & 2030
- 7.2. Type Segment Dashboard
- 7.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 7.4. Blood Tests
- 7.4.1. Blood Tests Market, 2018 - 2030 (USD Million)
- 7.5. Urinalysis
- 7.5.1. Urinalysis Market, 2018 - 2030 (USD Million)
Chapter 8. Europe Hospital Acquired Infections Diagnostics Market: Regional Estimates & Trend Analysis
- 8.1. Country Market Share Analysis, 2024 & 2030
- 8.2. Country Market Dashboard
- 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 8.4. UK
- 8.4.1. Key Country Dynamics
- 8.4.2. Regulatory Framework
- 8.4.3. Competitive Insights
- 8.4.4. UK Hospital Acquired Infections Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5. Germany
- 8.5.1. Key Country Dynamics
- 8.5.2. Regulatory Framework
- 8.5.3. Competitive Insights
- 8.5.4. Germany Hospital Acquired Infections Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6. France
- 8.6.1. Key Country Dynamics
- 8.6.2. Regulatory Framework
- 8.6.3. Competitive Insights
- 8.6.4. France Hospital Acquired Infections Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.7. Italy
- 8.7.1. Key Country Dynamics
- 8.7.2. Regulatory Framework
- 8.7.3. Competitive Insights
- 8.7.4. Italy Hospital Acquired Infections Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8. Spain
- 8.8.1. Key Country Dynamics
- 8.8.2. Regulatory Framework
- 8.8.3. Competitive Insights
- 8.8.4. Spain Hospital Acquired Infections Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.9. Norway
- 8.9.1. Key Country Dynamics
- 8.9.2. Regulatory Framework
- 8.9.3. Competitive Insights
- 8.9.4. Norway Hospital Acquired Infections Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.10. Denmark
- 8.10.1. Key Country Dynamics
- 8.10.2. Regulatory Framework
- 8.10.3. Competitive Insights
- 8.10.4. Denmark Hospital Acquired Infections Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.11. Sweden
- 8.11.1. Key Country Dynamics
- 8.11.2. Regulatory Framework
- 8.11.3. Competitive Insights
- 8.11.4. Sweden Hospital Acquired Infections Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.12. Russia
- 8.12.1. Key Country Dynamics
- 8.12.2. Regulatory Framework
- 8.12.3. Competitive Insights
- 8.12.4. Russia Hospital Acquired Infections Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.13. Netherlands
- 8.13.1. Key Country Dynamics
- 8.13.2. Regulatory Framework
- 8.13.3. Competitive Insights
- 8.13.4. Netherlands Hospital Acquired Infections Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Participant Overview
- 9.2. Company Market Position Analysis
- 9.3. Company Categorization
- 9.4. Strategy Mapping
- 9.5. Company Profiles/Listing
- 9.5.1. BIOMERIEUX
- 9.5.1.1. Overview
- 9.5.1.2. Financial Performance
- 9.5.1.3. Product Benchmarking
- 9.5.1.4. Strategic Initiatives
- 9.5.2. Abbott
- 9.5.2.1. Overview
- 9.5.2.2. Financial Performance
- 9.5.2.3. Product Benchmarking
- 9.5.2.4. Strategic Initiatives
- 9.5.3. F. Hoffmann-La Roche Ltd
- 9.5.3.1. Overview
- 9.5.3.2. Financial Performance
- 9.5.3.3. Product Benchmarking
- 9.5.3.4. Strategic Initiatives
- 9.5.4. Siemens Healthineers AG
- 9.5.4.1. Overview
- 9.5.4.2. Financial Performance
- 9.5.4.3. Product Benchmarking
- 9.5.4.4. Strategic Initiatives
- 9.5.5. BD
- 9.5.5.1. Overview
- 9.5.5.2. Financial Performance
- 9.5.5.3. Product Benchmarking
- 9.5.5.4. Strategic Initiatives
- 9.5.6. HC Bioscience
- 9.5.6.1. Overview
- 9.5.6.2. Financial Performance
- 9.5.6.3. Product Benchmarking
- 9.5.6.4. Strategic Initiatives
- 9.5.7. QIAGEN
- 9.5.7.1. Overview
- 9.5.7.2. Financial Performance
- 9.5.7.3. Product Benchmarking
- 9.5.7.4. Strategic Initiatives
- 9.5.8. Thermo Fisher Scientific Inc.
- 9.5.8.1. Overview
- 9.5.8.2. Financial Performance
- 9.5.8.3. Product Benchmarking
- 9.5.8.4. Strategic Initiatives
- 9.5.9. Meridian Bioscience, Inc.
- 9.5.9.1. Overview
- 9.5.9.2. Financial Performance
- 9.5.9.3. Product Benchmarking
- 9.5.9.4. Strategic Initiatives
- 9.5.10. Hologic, Inc.
- 9.5.10.1. Overview
- 9.5.10.2. Financial Performance
- 9.5.10.3. Product Benchmarking
- 9.5.10.4. Strategic Initiatives
- 9.5.1. BIOMERIEUX
Product Code: GVR-4-68040-513-7
List of Tables
- Table 1. List of secondary sources
- Table 2. List of abbreviations
- Table 3. Europe hospital acquired infections diagnostics market, by country, 2018 - 2030 (USD Million)
- Table 4. Europe hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
- Table 5. Europe hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
- Table 6. Europe hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 7. Europe hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
- Table 8. UK hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
- Table 9. UK hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
- Table 10. UK hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 11. UK hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
- Table 12. Germany hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
- Table 13. Germany hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
- Table 14. Germany hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 15. Germany hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
- Table 16. France hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
- Table 17. France hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
- Table 18. France hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 19. France hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
- Table 20. Italy hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
- Table 21. Italy hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
- Table 22. Italy hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 23. Italy hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
- Table 24. Spain hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
- Table 25. Spain hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
- Table 26. Spain hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 27. Spain hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
- Table 28. Denmark hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
- Table 29. Denmark hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
- Table 30. Denmark hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 31. Denmark hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
- Table 32. Sweden hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
- Table 33. Sweden hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
- Table 34. Sweden hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 35. Sweden hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
- Table 36. Norway hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
- Table 37. Norway hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
- Table 38. Norway hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 39. Norway hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
- Table 40. Russia hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
- Table 41. Russia hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
- Table 42. Russia hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 43. Russia hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
- Table 44. Netherlands hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
- Table 45. Netherlands hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
- Table 46. Netherlands hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
- Table 47. Netherlands hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Europe hospital acquired infections diagnostics market segmentation
- Fig. 2 Market research process
- Fig. 3 Data triangulation techniques
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Value-chain-based sizing & forecasting
- Fig. 7 Market formulation & validation
- Fig. 8 Market snapshot
- Fig. 9 Test type and infection type outlook (USD Million)
- Fig. 10 Product and type outlook (USD Million)
- Fig. 11 Competitive landscape
- Fig. 12 Europe hospital acquired infections diagnostics market dynamics
- Fig. 13 Europe hospital acquired infections diagnostics market: Porter's five forces analysis
- Fig. 14 Europe hospital acquired infections diagnostics market: PESTLE analysis
- Fig. 15 Europe hospital acquired infections diagnostics market: Test type segment dashboard
- Fig. 16 Europe hospital acquired infections diagnostics market: Test type market share analysis, 2024 & 2030
- Fig. 17 Molecular market, 2018 - 2030 (USD Million)
- Fig. 18 Conventional market, 2018 - 2030 (USD Million)
- Fig. 19 Europe hospital acquired infections diagnostics market: Infection type segment dashboard
- Fig. 20 Europe hospital acquired infections diagnostics market: Infection type market share analysis, 2024 & 2030
- Fig. 21 UTI market, 2018 - 2030 (USD Million)
- Fig. 22 Pneumonia market, 2018 - 2030 (USD Million)
- Fig. 23 Surgical site infection market, 2018 - 2030 (USD Million)
- Fig. 24 Blood stream infections market, 2018 - 2030 (USD Million)
- Fig. 25 Others market, 2018 - 2030 (USD Million)
- Fig. 26 Europe hospital acquired infections diagnostics market: Product segment dashboard
- Fig. 27 Europe hospital acquired infections diagnostics market: Product market share analysis, 2024 & 2030
- Fig. 28 Consumables market, 2018 - 2030 (USD Million)
- Fig. 29 Instruments market, 2018 - 2030 (USD Million)
- Fig. 30 Europe hospital acquired infections diagnostics market: Type segment dashboard
- Fig. 31 Europe hospital acquired infections diagnostics market: Type market share analysis, 2024 & 2030
- Fig. 32 Blood tests market, 2018 - 2030 (USD Million)
- Fig. 33 Urinalysis market, 2018 - 2030 (USD Million)
- Fig. 34 Europe hospital acquired infections diagnostics market revenue, by region
- Fig. 35 Regional marketplace: Key takeaways
- Fig. 36 Regional marketplace: Key takeaways
- Fig. 37 UK country dynamics
- Fig. 38 UK hospital acquired infections diagnostics market, 2018 - 2030 (USD Million)
- Fig. 39 Germany country dynamics
- Fig. 40 Germany hospital acquired infections diagnostics market, 2018 - 2030 (USD Million)
- Fig. 41 France country dynamics
- Fig. 42 France hospital acquired infections diagnostics market, 2018 - 2030 (USD Million)
- Fig. 43 Italy country dynamics
- Fig. 44 Italy hospital acquired infections diagnostics market, 2018 - 2030 (USD Million)
- Fig. 45 Spain country dynamics
- Fig. 46 Spain hospital acquired infections diagnostics market, 2018 - 2030 (USD Million)
- Fig. 47 Norway country dynamics
- Fig. 48 Norway hospital acquired infections diagnostics market, 2018 - 2030 (USD Million)
- Fig. 49 Sweden country dynamics
- Fig. 50 Sweden hospital acquired infections diagnostics market, 2018 - 2030 (USD Million)
- Fig. 51 Denmark country dynamics
- Fig. 52 Denmark hospital acquired infections diagnostics market, 2018 - 2030 (USD Million)
- Fig. 53 Russia country dynamics
- Fig. 54 Russia hospital acquired infections diagnostics market, 2018 - 2030 (USD Million)
- Fig. 55 Netherlands country dynamics
- Fig. 56 Netherlands hospital acquired infections diagnostics market, 2018 - 2030 (USD Million)
- Fig. 57 Company categorization
- Fig. 58 Company market position analysis
- Fig. 59 Strategic framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.